Variability of hepatitis C virus

Hepatology

Volumn 21, Issue 2, 1995, Pages 570-583

  Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; NOMENCLATURE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS TYPING;

BASE SEQUENCE; CHROMOSOME MAPPING; COMPARATIVE STUDY; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN; INTERFERONS; MOLECULAR SEQUENCE DATA; PHYLOGENY; TERMINOLOGY; VARIATION (GENETICS);

EID: 0028905430     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90121-3     Document Type: Article

References (105)

1. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Isolation of cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis
4. Genetic organization and diversity of the hepatitis C virus
5. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end
6. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the flaviviridae
7. Flavivirus genome organisation, expression and replication
8. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction
9. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
10. Structure and organization of the hepatitis C virus genome isolated from human carriers
11. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes
12. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions
13. A new type of hepatitis C virus in patients in Thailand
14. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
15. There are two major types of hepatitis C virus in Japan
16. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the Ns-5 region
17. Sequence variability in the 5′ non coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity
18. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide
19. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, El and NS-5 regions
20. Derivation of a rational nomenclature for hepatitis C virus by phylogenetic analysis of the NS-5 region
21. Typing of hepatitis C virus (HCV) genomes by restriction fragment length polymorphisms
22. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities
23. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay
24. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease
25. A proposed system for the nomenclature of hepatitis C viral genotypes
26. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
27. Genomic characterisation and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic on non-A, non-B hepatitis in Japan
28. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability
29. Analysis of genomic variability of hepatitis C virus
30. Internal ribosome entry site within hepatitis C virus RNA
31. Secondary structure of the 5′ nontranslated region of hepatitis C virus and pestivirus genomic RNAs
32. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism
33. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus
34. Serological reactivity of blood donors infected with three different types of hepatitis C virus
35. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain
36. Identification of hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region
37. Sequence analysis of the 5′ noncoding region of hepatitis C virus
38. At least five related, but distinct, hepatitis C viral genotypes exist
39. Geographical distribution of different hepatitis C virus genotypes in blood donors an international collaborative survey
40. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in the Netherlands
41. Use of the 5′ non-coding region for genotyping hepatitis C virus
42. Genotypes of hepatitis C virus in italian patients with chronic hepatitis C
43. Heterogeneity of hepatitis C virus genotypes in France
44. Application of hepatitis C virus genotyping systems in United States patients with chronic hepatitis C
45. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh
46. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors
47. High HCV prevalence in egyptian blood donors
48. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
49. High level of hepatitis C endemicity in Gabon, Equatorial Africa
50. New genotype of hepatitis C virus in SouthAfrica
51. Distribution of plural HCV types in Japan
52. Clinical backgrounds of the patients having different types of hepatitis C virus genomes
53. Genomic typing of hepatitis C viruses present in China
54. HCV genotypes in China
55. HCV genotypes in different countries
56. Differences in the hepatitis C virus genotypes in different countries
57. Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease
58. Imported hepatitis C virus genotypes in Japanese hemophiliacs
59. Genotypic subtyping of hepatitis C virus
60. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group
61. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources
62. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection
63. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV)-use of type-specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3
64. Significance of specific antibody assay for genotyping of hepatitis C virus
65. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus
66. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
67. Non responders to interferon therapy among chronic hepatitis patients infected with hepatitis C virus
68. Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C
69. Response related factors in recombinant interferon-alfa-2b treatment of chronic hepatitis C
70. Factors useful in predicting the response to interferon therapy in chronic hepatitis C
71. Prediction of the response of chronic hepatitis C to interferon-alfa-a statistical analysis of pretreatment variables
72. Factors predictive of response to interferonalpha therapy in hepatitis C virus infection
73. HCV genotypes in chronic hepatitis C and response to interferon
74. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta
75. Hepatitis C virus genotypes-an investigation of type-specific differences in geographic origin and disease
76. Hepatitis C serotype and response to interferon therapy
77. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA
78. Antiviral effect of lymphoblastoid interferon-alpha on hepatitis C virus in patients with chronic hepatitis type C
79. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
80. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus
81. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections
82. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses
83. Hypervariable regions in the putative glycoprotein of hepatitis C virus
84. Genetic drift of hepatitis-c virus during an 8.2-year infection in a chimpanzee-variability and stability
85. Humoral immune response to hypervariable region-1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
86. Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants
87. A structurally flexible and antigenically variable n-terminal domain of the hepatitis C virus e2/ NS1 protein-implication for an escape from antibody
88. The degree of variability in the amino terminal region of the E2/ NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viraemic patients
89. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection
90. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo
91. Persistence of HCV despite antibodies to both putative envelope glycoproteins
92. Detection by western blotting of an antibody to the hepatitis C virus El envelope protein in sera of patients with chronic liver disease
93. Intrahepatic cytotoxic T lymphocytes specific for hepatitis-c virus in persons with chronic hepatitis
94. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
95. Lack of protective immunity against reinfection with hepatitis C virus
96. Immunity in hepatitis C infection
97. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
98. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins
99. Phylogenetic analysis of a new, highly divergent HCV type (type 3): effect of sequence variability on serological responses to infection
100. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease
101. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein
102. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates
103. The entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a